NCT00093353 2026-04-14N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant NeuroblastomaNew Approaches to Neuroblastoma Therapy ConsortiumPhase 1 Completed30 enrolled